Ruti Aga banned for six years: forged prescription destroyed her defence, and calling a glucocorticoid a ‘steroid’ misses the legal point

Ruti Aga, the 32-year-old Ethiopian marathon runner, has been banned for six years by the Athletics Integrity Unit (AIU) after testing positive for methylprednisolone at a half marathon in China in March and then submitting a forged prescription during the investigation. The case is less about a prohibited substance than about the collapse of medical governance around an injured elite road runner. The AIU said on Thursday that Aga received two years for the presence violation and four years for tampering, making six years in total. The sanction is dated from 10 September, the same date her provisional suspension began. The statement does not specify the year of the March race, but the reference to a provisional suspension since 10 September strongly suggests this is a current-year case. The case began when Aga won a half marathon in China and was tested. Methylprednisolone was found in her sample. She explained that she had a knee injury and had received the drug as treatment. From a sports-medicine perspective, that is not implausible: intra-articular or peri-articular glucocorticoid injections for knee inflammation are common in distance runners. But the explanation was legally fatal because a genuine treatment claim needed genuine medical records. A key technical point has been widely misreported. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List. Anabolic steroids are class S1. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes. Therapeutic use out of competition can be entirely lawful. That means the case turned on route of administration and timing relative to the competition, not on ‘steroid use’. In road running, the in-competition testing window opens at 23:59 the day before the race. A glucocorticoid injected days earlier can still be present in-competition. A defence was available: correct timing, correct route and real medical documentation. Aga closed that route by fabricating documents. The arithmetic is revealing. Two years for presence is consistent with a specified-substance finding without proven intent. Four years is the standard Code sanction for tampering. The panel evidently rejected a no-significant-fault argument that could have reduced the presence sanction. In other words, the forged document destroyed the mitigation that might otherwise have been available. The forgery chain involved three independent verification failures: the person who issued the prescription was a family member with no medical registration; the clinic named on the document did not exist; and the claim that an ‘old prescription pad from a former workplace’ had been used was explicitly rejected by the clinic. This is not a filing error. It is the signature of an athlete operating without a credentialed team physician. A properly managed athlete would either hold or apply for a Therapeutic Use Exemption, or observe WADA’s route-specific washout period. Neither appears to have happened. The attempt to manufacture a paper trail suggests informal treatment rather than a single lapse. For Aga, the practical consequence is career-terminal. She is 32. By the time a six-year ban expires she will be about 38. Ethiopian women’s marathon depth is so extreme that a 38-year-old returning athlete with a doping record is effectively unselectable. The 2028 Olympic cycle is closed to her. The ban is six years on paper; in elite terms it is a lifetime ban. Her record remains that of a genuinely elite marathoner: victory at the 2026 Tokyo Marathon and three second-place finishes at World Marathon Majors. External records list personal bests of around 2:18:34 in Berlin 2026 and 2:20:40 in Tokyo 2026, but those figures are not in the AIU statement and should be treated as unverified. The statement is confined to the sanction, her age and the nature of the case. The March result and its prize money are very likely annulled, although the statement does not say so explicitly. Standard AIU practice is automatic disqualification of the competition where the sample was collected, with ranking points from that date also removed. Results before the violation are not automatically affected absent evidence of earlier use. That distinction matters: titles and records are not the same thing as the scope of a sanction. The competitive landscape is largely unaffected. Aga’s removal changes nothing in Ethiopian selection calculus: a 2:18–2:20 performer is not automatically selectable in a country with world-record-class depth. Kenya has comparable depth. One athlete’s exit is invisible at national-team level. The real subject is governance and integrity, not medal capacity. The commercial economy of road racing is central. Between Majors, Asian label races are a lucrative income tier for East African marathoners: appearance fees, prize money and lower competitive risk. That same tier is now one of the AIU’s highest-yield testing grounds. The appearance-fee economy and the testing economy are colliding in the same races. China’s label-race circuit is a clear example: large appearance-fee budgets, deep East African elite fields and growing AIU scrutiny. Integrity risk in this tier will rise. Aga’s case came from this circuit. The statement does not name the race, venue or exact date, which raises transparency questions. The tampering charge also rests partly on statements made in interview, not only on documents. Language and translation conditions in AIU interviews with Ethiopian athletes have been a recurring point of contention. The case reopens the question of whether athletes receive adequate legal and linguistic support during investigations. An appeal to the Court of Arbitration for Sport is possible, typically within about 21 days of the reasoned decision, but the prospects are weak. The central finding is documentary, and the clinic itself disowned the document. A document-based finding is hard to overturn. Criminal exposure for document forgery is possible but outside the AIU’s jurisdiction; the statement does not say whether any referral was made. Nor does it say whether an agent or management figure was investigated. The proportionality debate will continue. One argument is that a six-year ban for a glucocorticoid with no proven endurance benefit is harsh. The other is that the sanction punishes not the drug but the forged document and misleading statements, which cannot be treated lightly. Both readings capture part of the case. The case will also be cited in the debate over enforcement against African road runners. The AIU can argue that rigor is necessary for integrity. Critics can argue that athletes without resources do not receive the legal support available to richer federations. Both can be true. What is clear is that the athlete weakened her own defence with a fabricated document. The lesson is that injury treatment and anti-doping compliance must be part of one system. Every injection, every medication and every prescription should be documented; TUE status should be clear; washout periods should be known before testing. That is not only the athlete’s responsibility but also that of management, coaches and team doctors. Where that system is absent, fabricated paperwork becomes more likely. Several questions remain unanswered: the year of the March race, the exact end date of the ban, whether the result and prize money were annulled, the Ethiopian federation’s response, and whether any separate action will be taken against the family member. The AIU statement answers few of these. For journalism, that gap matters, because the severity of a sanction cannot be assessed without knowing its scope and consequences. For now, the picture is of a talented runner who won Tokyo in 2026, finished second at three Majors, and then lost her career in a cycle of knee injury, informal treatment and a forged prescription. The story is not only about doping. It is about an ecosystem that offers athletes cheap, fast and informal solutions—and in which the instinct to conceal, rather than correct, grows stronger when a mistake is detected.